- Home
- ELVN vs NBN Comparison
ELVN vs NBN Comparison
Compare ELVN & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- NBN
- Stock Information
- Founded
- ELVN 2016
- NBN 1872
- Country
- ELVN United States
- NBN United States
- Employees
- ELVN N/A
- NBN N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- NBN Major Banks
- Sector
- ELVN Health Care
- NBN Finance
- Exchange
- ELVN Nasdaq
- NBN Nasdaq
- Market Cap
- ELVN 927.8M
- NBN 766.7M
- IPO Year
- ELVN 2020
- NBN N/A
- Fundamental
- Price
- ELVN $17.77
- NBN $83.83
- Analyst Decision
- ELVN Strong Buy
- NBN Buy
- Analyst Count
- ELVN 4
- NBN 2
- Target Price
- ELVN $37.25
- NBN $97.50
- AVG Volume (30 Days)
- ELVN 361.5K
- NBN 38.0K
- Earning Date
- ELVN 05-14-2025
- NBN 07-28-2025
- Dividend Yield
- ELVN N/A
- NBN 0.05%
- EPS Growth
- ELVN N/A
- NBN 23.53
- EPS
- ELVN N/A
- NBN 8.99
- Revenue
- ELVN N/A
- NBN $184,337,000.00
- Revenue This Year
- ELVN N/A
- NBN $36.62
- Revenue Next Year
- ELVN N/A
- NBN $11.46
- P/E Ratio
- ELVN N/A
- NBN $9.32
- Revenue Growth
- ELVN N/A
- NBN 24.54
- 52 Week Low
- ELVN $13.30
- NBN $54.50
- 52 Week High
- ELVN $30.03
- NBN $110.35
- Technical
- Relative Strength Index (RSI)
- ELVN 49.54
- NBN 45.37
- Support Level
- ELVN $15.81
- NBN $81.63
- Resistance Level
- ELVN $17.54
- NBN $86.79
- Average True Range (ATR)
- ELVN 1.30
- NBN 2.01
- MACD
- ELVN -0.04
- NBN 0.06
- Stochastic Oscillator
- ELVN 38.06
- NBN 24.66
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.